Home›Trial›NCT03531255
🔬NCT03531255Phase 3ACTIVE NOT RECRUITING

Pegcetacoplan Long Term Safety and Efficacy Extension Study

Study Summary

This is an Open-label, Non-Randomized, Multi-Center Extension Study. Eligible subjects will have previously completed a pegcetacoplan study.

Conditions
PNH
Interventions / Drugs
Pegcetacoplan
View on ClinicalTrials.gov ↗
Sponsor
APLS
Apellis Pharmaceuticals
Complement Inhibitors
D36/100
Study Details
Enrollment160 participants
Primary Completion—
Lead SponsorApellis Pharmaceuticals, Inc.
Data Retrieved2026-04-11 02:54:08.046057+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.